Arrowhead Pharmaceuticals, Inc. (LON:0HI3)

Arrowhead Pharmaceuticals Statistics

Total Valuation

LON:0HI3 has a market cap or net worth of GBP 6.26 billion. The enterprise value is 6.15 billion.

Market Cap	6.26B
Enterprise Value	6.15B

Important Dates

The last earnings date was Wednesday, November 26, 2025.

Earnings Date	Nov 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	135.81M
Shares Outstanding	n/a
Shares Change (YoY)	+11.67%
Shares Change (QoQ)	-0.84%
Owned by Insiders (%)	3.98%
Owned by Institutions (%)	75.57%
Float	116.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.15
PB Ratio	16.72
P/TBV Ratio	18.33
P/FCF Ratio	53.66
P/OCF Ratio	46.89
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 59.07, with an EV/FCF ratio of 52.72.

EV / Earnings	-5,070.92
EV / Sales	9.88
EV / EBITDA	59.07
EV / EBIT	83.36
EV / FCF	52.72

Financial Position

The company has a current ratio of 4.86, with a Debt / Equity ratio of 1.46.

Current Ratio	4.86
Quick Ratio	4.73
Debt / Equity	1.46
Debt / EBITDA	5.29
Debt / FCF	4.68
Interest Coverage	1.10

Financial Efficiency

Return on equity (ROE) is 8.67% and return on invested capital (ROIC) is 5.39%.

Return on Equity (ROE)	8.67%
Return on Assets (ROA)	4.87%
Return on Invested Capital (ROIC)	5.39%
Return on Capital Employed (ROCE)	8.27%
Revenue Per Employee	867,876
Profits Per Employee	-1,707
Employee Count	711
Asset Turnover	0.66
Inventory Turnover	n/a

Taxes

In the past 12 months, LON:0HI3 has paid 15.93 million in taxes.

Income Tax	15.93M
Effective Tax Rate	41.56%

Stock Price Statistics

The stock price has increased by +177.51% in the last 52 weeks. The beta is 1.31, so LON:0HI3's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	+177.51%
50-Day Moving Average	42.20
200-Day Moving Average	23.82
Relative Strength Index (RSI)	72.23
Average Volume (20 Days)	6,246

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.95

Income Statement

In the last 12 months, LON:0HI3 had revenue of GBP 617.06 million and -1.21 million in losses. Loss per share was -0.01.

Revenue	617.06M
Gross Profit	617.06M
Operating Income	73.16M
Pretax Income	38.34M
Net Income	-1.21M
EBITDA	90.96M
EBIT	73.16M
Loss Per Share	-0.01

Balance Sheet

The company has 682.54 million in cash and 545.81 million in debt, giving a net cash position of 136.73 million.

Cash & Cash Equivalents	682.54M
Total Debt	545.81M
Net Cash	136.73M
Net Cash Per Share	n/a
Equity (Book Value)	374.51M
Book Value Per Share	2.55
Working Capital	561.79M

Cash Flow

In the last 12 months, operating cash flow was 133.58 million and capital expenditures -16.86 million, giving a free cash flow of 116.71 million.

Operating Cash Flow	133.58M
Capital Expenditures	-16.86M
Free Cash Flow	116.71M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 11.86% and -0.20%.

Gross Margin	100.00%
Operating Margin	11.86%
Pretax Margin	6.21%
Profit Margin	-0.20%
EBITDA Margin	14.74%
EBIT Margin	11.86%
FCF Margin	18.91%

Dividends & Yields

LON:0HI3 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.67%
Shareholder Yield	-11.67%
Earnings Yield	-0.02%
FCF Yield	1.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HI3 has an Altman Z-Score of 1.51 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.51
Piotroski F-Score	5